A carregar...
TARGETING STAT3 ABROGATES EGFR INHIBITOR RESISTANCE IN CANCER
PURPOSE: EGFR is upregulated in most epithelial cancers where signaling through EGFR contributes to cancer cell proliferation and survival. The limited clinical efficacy of EGFR inhibitors suggests that identification of resistance mechanisms may identify new pathways for therapeutic targeting. Sign...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3445706/ https://ncbi.nlm.nih.gov/pubmed/22825581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-0792 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|